Intravenous cyclophosphamide pulse therapy in interstitial lung disease associated with systemic sclerosis in a retrospective open-label study: influence of the extent of inflammation on pulmonary function.

Clin Rheumatol · 2018 · PMC6154086 · PMID 29987427

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

The second, the UK lung study, showed a trend towards improvement of forced vital capacity (FVC) after six monthly intravenous (IV) CYC pulses during 12 months compared to placebo.

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.